Botox study for skin disease pulled before it started
NCT ID NCT06237465
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if Botulinum Toxin-A (Botox) could help people with hidradenitis suppurativa, a painful skin condition. It planned to enroll adults with active armpit lesions of similar severity on both sides. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale Medicine Multispecialty Clinic
Guilford, Connecticut, 06437, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection tame the painful lumps of hidradenitis suppurativa?
- Can brain scans reveal the hidden toll of hidradenitis suppurativa?
- Could botox calm the painful skin flares of hidradenitis suppurativa?
- Could childhood trauma fuel skin inflammation?
- Can Real-World data unlock better skin disease care?
- Can an oral Anti-Inflammatory drug tame a painful skin condition?